We are live on ! Find out more
AFM

Anson Funds Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 370.24%
This Fund
S&P 500
This Quarter Est. Return
-8.42%
1 Year Est. Return
+370.24%
3 Year Est. Return
+1,243.07%
5 Year Est. Return
+867.54%
10 Year Est. Return
+12,575.88%
AUM
$136K
AUM Growth
-$70.3K
Cap. Flow
-$21.1M
Cap. Flow %
-15,502.66%
Top 10 Hldgs %
88.94%
Holding
54
New
15
Increased
5
Reduced
4
Closed
20

Top Buys

Rank Stock Value
1
SRAX
SRAX, Inc. Class A Common Stock
SRAX
+$3.34M
2
DMK
DMK Pharmaceuticals Corporation Common Stock
DMK
+$1.48M
3
BPY
Brookfield Property Partners L.P. Limited Partnership Units
BPY
+$1.35M
4
VRE
Veris Residential
VRE
+$1.33M
5
AIM
AIM ImmunoTech
AIM
+$1.25M

Top Sells

Rank Stock Value
1
AGX icon
Argan
AGX
+$1.41M
2
BN icon
Brookfield
BN
+$254K
3
HPP
Hudson Pacific Properties
HPP
+$85.2K
4
BHC icon
Bausch Health
BHC
+$14.7K
5
OR icon
OR Royalties Inc
OR
+$4.01K

Sector Composition

Rank Sector Weight
1 Real Estate 6.62%
2 Consumer Staples 2.47%
3 Industrials 2.04%
4 Communication Services 1.77%
5 Healthcare 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHIPZ
26
DELISTED
Seanergy Maritime Holdings Corp Class B Warrant
SHIPZ
$351 0.26%
+730,000
New +$135K
NSPRZ
27
DELISTED
InspireMD, Inc. Series B Warrants
NSPRZ
$325 0.24%
250,000
– –
RESI
28
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$289 0.21%
+25,000
New +$289K
TOON icon
29
Kartoon Studios
TOON
$34.5M
$286 0.21%
+44,573
New +$386K
SNR
30
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$167 0.12%
+25,000
New +$166K
PHIOW
31
DELISTED
Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021
PHIOW
$60 0.04%
217,023
– –
MDGSW
32
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$36 0.03%
21,000
+5,375
+34% +$2.59K
ALBT
33
DELISTED
Avalon GloboCare
ALBT
– –
-788
Closed -$307
BHC icon
34
Bausch Health
BHC
$1.68B
– –
-581,569
Closed -$14.7K
COLD icon
35
Americold
COLD
$4.19B
– –
-10,000
Closed -$324
CRVO icon
36
CervoMed
CRVO
$23.6M
– –
-4,365
Closed -$933
HBM icon
37
Hudbay
HBM
$9.73B
– –
-370,000
Closed -$2K
HST icon
38
Host Hotels & Resorts
HST
$17.5B
– –
-53,500
Closed -$975
IGC icon
39
IGC Pharma
IGC
$27M
– –
-94,353
Closed -$155
INVH icon
40
Invitation Homes
INVH
$17.9B
– –
-18,439
Closed -$493
LGMK
41
DELISTED
LogicMark
LGMK
– –
-398
Closed -$1.47K
NUWE icon
42
Nuwellis
NUWE
$172K
– –
0
– -$278
OR icon
43
OR Royalties Inc
OR
$5.41B
– –
-375,000
Closed -$4.01K
PLD icon
44
Prologis
PLD
$134B
– –
-8,500
Closed -$681
SHIP icon
45
Seanergy Maritime Holdings
SHIP
$346M
– –
-1,644
Closed -$163
SLS icon
46
SELLAS Life Sciences
SLS
$1.98B
– –
-9,275
Closed -$52
SONN
47
DELISTED
Sonnet BioTherapeutics
SONN
– –
-3
Closed -$214
TLRY icon
48
CALL
Tilray
TLRY
$477M
– –
-8,900
Closed -$4.14K
VUZI icon
49
PUT
Vuzix
VUZI
$181M
– –
-169,200
Closed -$692
PRVB
50
DELISTED
Provention Bio, Inc. Common Stock
PRVB
– –
-159,337
Closed -$1.93K
1
2
3

Similar funds

LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
ST
Smithfield Trust Pittsburgh, Pennsylvania $2.3B AUM 14.87% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
7WCP
71 West Capital Partners Boston, Massachusetts $2.27B AUM
LFM
LGT Fund Management Vaduz, Liechtenstein $2.3B AUM 22.66% 1-Year Est. Return

Anson Funds Management's Q3 2019 Portfolio in Review

As of Q3 2019, Anson Funds Management held 54 positions worth $136K, down 34% from $207K the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Anson Funds Management withdrew a net $21.1M in Q3 2019, closing 20 positions and reducing 4 holdings. Its most notable exit was Bausch Health, an estimated $14.7K position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 6.6% of assets, up from 4.9% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, Anson Funds Management opened a new position in SRAX, Inc. Class A Common Stock worth $2.12K.

  • Anson Funds Management's largest Q3 2019 buy was SRAX, Inc. Class A Common Stock: 923,626 shares worth $2.12K.
  • Anson Funds Management added most to Veris Residential in Q3 2019, an estimated $1.33M increase.
  • Anson Funds Management's biggest Q3 2019 reduction was Argan, cutting an estimated $1.41M.
  • Anson Funds Management fully exited Bausch Health in Q3 2019, selling an estimated $14.7K.
  • Anson Funds Management's ten largest holdings make up 89% of its $136K portfolio in Q3 2019.
  • Anson Funds Management opened 15 new positions and closed 20 in Q3 2019.
  • Anson Funds Management's portfolio value fell 34% quarter-over-quarter to $136K.

Based on Anson Funds Management's 13F filing for Q3 2019, filed 14 Nov 2019.